Skip to main content
Erschienen in: Journal of Cancer Education 5/2020

21.06.2019

Psychometric Properties of the MICRA Questionnaire in Portuguese Individuals Carrying SDHx Mutations

verfasst von: Raquel Gomes Martins, Irene Palmares Carvalho

Erschienen in: Journal of Cancer Education | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

This study aims to present the translation and cultural adaptation, as well as the psychometric characteristics of the Portuguese version of the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire in individuals with SDHx mutations. The questionnaire was translated and culturally adapted in accordance with the process recommended by the World Health Organization. As per suggestion of the authors of the original instrument, a joint, universal European and Brazilian Portuguese version of the MICRA was created. Ninety-six (asymptomatic or affected) patients with SDHx mutations nationwide completed the adapted version of the MICRA in Portugal. Analyses consisted of confirmatory factor analysis, reliability estimation (alphas), and correlations with two other distress and quality of life instruments. The Portuguese adaptation of the MICRA was understandable to patients from various socioeconomic backgrounds. All items and factor structure of the original version were retained, yielding a good model fit. The MICRA’s three subscales and total score showed good internal consistency, and the correlations found between the Portuguese version of the MICRA and the other instruments assessing similar constructs further supported its validity. The adapted version of the MICRA showed good psychometric properties with a representative population of SDHx mutation carriers. This instrument can now be used to study the multidimensional impact of taking a genetic test for these mutations. It can also be used in future studies with other Portuguese populations of patients submitted to genetic tests for cancer risk assessment.
Literatur
2.
Zurück zum Zitat Lenders, J. W., Duh, Q. Y., Eisenhofer, G., Gimenez-Roqueplo, A. P., Grebe, S. K., Murad, M. H., Naruse M., Pacak K., Young WF Jr, Endocrine Society. (2014). Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab, 99(6), 1915–1942, doi:https://doi.org/10.1210/jc.2014-1498 Lenders, J. W., Duh, Q. Y., Eisenhofer, G., Gimenez-Roqueplo, A. P., Grebe, S. K., Murad, M. H., Naruse M., Pacak K., Young WF Jr, Endocrine Society. (2014). Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab, 99(6), 1915–1942, doi:https://​doi.​org/​10.​1210/​jc.​2014-1498
4.
Zurück zum Zitat Brito JP, Asi N, Bancos I, Gionfriddo MR, Zeballos-Palacios CL, Leppin AL, Undavalli C, Wang Z, Domecq JP, Prustsky G, Elraiyah TA, Prokop LJ, Montori VM, Murad MH (2015) Testing for germline mutations in sporadic pheochromocytoma/paraganglioma: a systematic review. Clin Endocrinol 82(3):338–345. https://doi.org/10.1111/cen.12530CrossRef Brito JP, Asi N, Bancos I, Gionfriddo MR, Zeballos-Palacios CL, Leppin AL, Undavalli C, Wang Z, Domecq JP, Prustsky G, Elraiyah TA, Prokop LJ, Montori VM, Murad MH (2015) Testing for germline mutations in sporadic pheochromocytoma/paraganglioma: a systematic review. Clin Endocrinol 82(3):338–345. https://​doi.​org/​10.​1111/​cen.​12530CrossRef
5.
Zurück zum Zitat Cella D, Hughes C, Peterman A, Chang CH, Peshkin BN, Schwartz MD, Wenzel L, Lemke A, Marcus AC, Lerman C (2002) A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire. Health Psychol 21(6):564–572CrossRefPubMed Cella D, Hughes C, Peterman A, Chang CH, Peshkin BN, Schwartz MD, Wenzel L, Lemke A, Marcus AC, Lerman C (2002) A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire. Health Psychol 21(6):564–572CrossRefPubMed
10.
13.
Zurück zum Zitat Graves KD, Vegella P, Poggi EA, Peshkin BN, Tong A, Isaacs C, Finch C, Kelly S, Taylor KL, Luta G, Schwartz MD (2012) Long-term psychosocial outcomes of BRCA1/BRCA2 testing: differences across affected status and risk-reducing surgery choice. Cancer Epidemiol Biomark Prev 21(3):445–455. https://doi.org/10.1158/1055-9965.epi-11-0991CrossRef Graves KD, Vegella P, Poggi EA, Peshkin BN, Tong A, Isaacs C, Finch C, Kelly S, Taylor KL, Luta G, Schwartz MD (2012) Long-term psychosocial outcomes of BRCA1/BRCA2 testing: differences across affected status and risk-reducing surgery choice. Cancer Epidemiol Biomark Prev 21(3):445–455. https://​doi.​org/​10.​1158/​1055-9965.​epi-11-0991CrossRef
14.
Zurück zum Zitat Graves KD, Wenzel L, Schwartz MD, Luta G, Wileyto P, Narod S, Peshkin BN, Marcus A, Cella D, Emsbo SP, Barnes D, Halbert CH (2010) Randomized controlled trial of a psychosocial telephone counseling intervention in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomark Prev 19(3):648–654. https://doi.org/10.1158/1055-9965.epi-09-0548CrossRef Graves KD, Wenzel L, Schwartz MD, Luta G, Wileyto P, Narod S, Peshkin BN, Marcus A, Cella D, Emsbo SP, Barnes D, Halbert CH (2010) Randomized controlled trial of a psychosocial telephone counseling intervention in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomark Prev 19(3):648–654. https://​doi.​org/​10.​1158/​1055-9965.​epi-09-0548CrossRef
16.
Zurück zum Zitat Hooker GW, Leventhal KG, DeMarco T, Peshkin BN, Finch C, Wahl E, Joines JR, Brown K, Valdimarsdottir H, Schwartz MD (2011) Longitudinal changes in patient distress following interactive decision aid use among BRCA1/2 carriers: a randomized trial. Med Decis Mak 31(3):412–421. https://doi.org/10.1177/0272989x10381283CrossRef Hooker GW, Leventhal KG, DeMarco T, Peshkin BN, Finch C, Wahl E, Joines JR, Brown K, Valdimarsdottir H, Schwartz MD (2011) Longitudinal changes in patient distress following interactive decision aid use among BRCA1/2 carriers: a randomized trial. Med Decis Mak 31(3):412–421. https://​doi.​org/​10.​1177/​0272989x10381283​CrossRef
19.
20.
Zurück zum Zitat World-Health-Organization (2016) Process of translation and adaptation of instruments. Accessed, pp 16–09-2016 World-Health-Organization (2016) Process of translation and adaptation of instruments. Accessed, pp 16–09-2016
21.
Zurück zum Zitat Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370CrossRefPubMed Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370CrossRefPubMed
22.
Zurück zum Zitat Snaith, R. P., & Zigmond, A. P. (1994). The Hospital Anxiety and Depression Scale Manual. Windsor: NFER-Nelson Snaith, R. P., & Zigmond, A. P. (1994). The Hospital Anxiety and Depression Scale Manual. Windsor: NFER-Nelson
24.
Zurück zum Zitat Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30(6):473–483CrossRefPubMed Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30(6):473–483CrossRefPubMed
25.
Zurück zum Zitat Ferreira PL (2000) Development of the Portuguese version of MOS SF-36. Part II --validation tests. Acta Medica Port 13(3):119–127 Ferreira PL (2000) Development of the Portuguese version of MOS SF-36. Part II --validation tests. Acta Medica Port 13(3):119–127
Metadaten
Titel
Psychometric Properties of the MICRA Questionnaire in Portuguese Individuals Carrying SDHx Mutations
verfasst von
Raquel Gomes Martins
Irene Palmares Carvalho
Publikationsdatum
21.06.2019
Verlag
Springer US
Erschienen in
Journal of Cancer Education / Ausgabe 5/2020
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-019-01562-x

Weitere Artikel der Ausgabe 5/2020

Journal of Cancer Education 5/2020 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.